A detailed history of New York State Common Retirement Fund transactions in Generation Bio Co. stock. As of the latest transaction made, New York State Common Retirement Fund holds 2,682 shares of GBIO stock, worth $3,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,682
Previous 2,682 -0.0%
Holding current value
$3,084
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$2.64 - $4.35 $60 - $100
23 Added 0.86%
2,682 $8,000
Q4 2023

Feb 01, 2024

SELL
$0.91 - $3.35 $100 - $368
-110 Reduced 3.97%
2,659 $4,000
Q3 2023

Nov 07, 2023

BUY
$3.65 - $6.9 $390 - $738
107 Added 4.02%
2,769 $10,000
Q2 2023

Aug 07, 2023

SELL
$3.5 - $5.67 $140 - $226
-40 Reduced 1.48%
2,662 $15,000
Q1 2023

May 02, 2023

SELL
$3.61 - $7.01 $84,239 - $163,578
-23,335 Reduced 89.62%
2,702 $12,000
Q4 2022

Jan 30, 2023

BUY
$3.66 - $6.77 $14 - $27
4 Added 0.02%
26,037 $102,000
Q3 2022

Nov 08, 2022

BUY
$4.68 - $8.34 $542 - $967
116 Added 0.45%
26,033 $138,000
Q2 2022

Aug 04, 2022

BUY
$4.87 - $9.41 $42,120 - $81,387
8,649 Added 50.09%
25,917 $170,000
Q1 2022

May 05, 2022

SELL
$4.16 - $7.76 $59,072 - $110,192
-14,200 Reduced 45.13%
17,268 $127,000
Q4 2021

Feb 02, 2022

SELL
$5.99 - $24.97 $850 - $3,545
-142 Reduced 0.45%
31,468 $223,000
Q3 2021

Nov 02, 2021

SELL
$20.0 - $27.43 $152,340 - $208,934
-7,617 Reduced 19.42%
31,610 $792,000
Q2 2021

Aug 02, 2021

BUY
$24.34 - $38.34 $414,437 - $652,815
17,027 Added 76.7%
39,227 $1.06 Million
Q1 2021

May 11, 2021

BUY
$24.74 - $40.2 $272,140 - $442,200
11,000 Added 98.21%
22,200 $632,000
Q4 2020

Feb 08, 2021

BUY
$21.68 - $51.61 $121,408 - $289,016
5,600 Added 100.0%
11,200 $318,000
Q3 2020

Nov 05, 2020

BUY
$18.07 - $31.84 $101,192 - $178,304
5,600 New
5,600 $173,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $67.9M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.